kneat.com (TSE:KSI) Sets New 12-Month High – Here’s What Happened

kneat.com, inc. (TSE:KSI)’s stock price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as C$6.53 and last traded at C$6.45, with a volume of 128055 shares trading hands. The stock had previously closed at C$6.39.

Analysts Set New Price Targets

KSI has been the subject of a number of recent research reports. Cibc World Mkts upgraded kneat.com to a “strong-buy” rating in a report on Tuesday, October 29th. CIBC set a C$6.00 price objective on shares of kneat.com and gave the stock an “outperform” rating in a research note on Tuesday, October 29th.

kneat.com Trading Up 0.9 %

The firm has a market cap of C$554.70 million, a P/E ratio of -40.31, a P/E/G ratio of 597.67 and a beta of 1.08. The company’s 50 day simple moving average is C$5.81 and its 200-day simple moving average is C$5.08. The company has a quick ratio of 1.50, a current ratio of 1.47 and a debt-to-equity ratio of 95.14.

kneat.com (TSE:KSI) last posted its quarterly earnings data on Wednesday, November 6th. The company reported C$0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C($0.05) by C$0.06. kneat.com had a negative return on equity of 51.13% and a negative net margin of 31.19%. During the same quarter in the previous year, the company posted ($0.05) earnings per share. As a group, research analysts predict that kneat.com, inc. will post -0.12 earnings per share for the current fiscal year.

kneat.com Company Profile

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.